There were 51 press releases posted in the last 24 hours and 170,087 in the last 365 days.

IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU

/EIN News/ -- NEW ORLEANS, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc. (NasdaqGM: IMMU), if they purchased the Company’s shares between August 23, 2018 and December 20, 2018, inclusive (the “Class Period”).  This action is pending in the United States District Court for the District of New Jersey.

What You May Do

If you purchased shares of Immunomedics and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaql-immu/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 25, 2019.

About the Lawsuit

Immunomedics and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On December 17, 2018, FDAnews.com reported in an article entitled “FDA Hits Immunomedics for Data Integrity Breach” that “the FDA cited Immunomedics for a host of violations-including its handling of a data integrity breach-observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.” Then, on December 20, 2018, Favus Institutional Research issued a report further detailing the breach.

On this news, the price of Immunomedics’ shares plummeted.

The case is Odeh v. Immunomedics, Inc. et al., No. 2:18-cv-17645.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

Logo -Color.jpg

Distribution channels: Consumer Goods, Law


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.